Cathepsin Inhibitors; Can Be Used to Treat Cancer, Ebola Infection, and Brain Injuries
Cathepsins are proteases found in all animals as well as other organisms. They are mainly found in acidic endo/lysosomal compartments where they play a vital role in intracellular protein degradation, energy metabolism, and immune responses among a host of other functions. There are distinctive variants of cathepsin inhibitors with each variation advertising different benefits and usefulness against various diseases, such as cancer, Ebola, brain injuries, and others. Thus, there is an increasing demand for cathepsin inhibitors worldwide.
According to the "Coherent
Market Insights" Global Industry Insights, Trends, Outlook, and
Opportunity Analysis of Cathepsin
Inhibitors Market.
Cathepsin Inhibitors Market |
There is an increasing demand for novel cancer treatment
approaches across the globe, owing to the increasing prevalence of cancer. For
instance, according to the American Cancer Society, in 2021, there will be an
estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in
the United States. Cathepsin D has been found to reduce the immune system's
anti-tumor response, and cathepsins B/L are heavily involved in cell invasion.
Cathepsin inhibitors stops cell invasion and subsequent metastasis, thereby
reducing the risk of cancer spread.
Although there are no approved cathepsin inhibitors in the
market, research and development activities are under process for the
development of novel cathepsin inhibitors to treat various health conditions. Moreover,
cathepsin inhibitors (cathepsin L) were found to prevent severe acute
respiratory syndrome coronavirus (SARS) entry. Moreover, a cell-free
membrane-fusion system showed that cathepsin L is sufficient to activate
membrane fusion by SARS-CoV S.
One class of protein targets that have shown promising
results are proteolytic enzymes that involve multiple host proteases involved
in viral entry, replication, and effects on the immune system causing the
life-threatening symptoms of COVID-19. Furthermore, several members of the
cathepsin family of cysteine proteases, including furin, cathepsin L, and the
serine proteases factor Xa, tryptase, elastase, plasmin, TMPRSS4, and TMPRSS2,
among others. Inhibition of the Cathepsin L and Furin protease might therefore
be an efficient way to attenuate the infection process and reduce the spread
and severity of COVID-19.
Comments
Post a Comment